Article Versions Notes

Manna M, Gelmon KA, Boileau J-F, Brezden-Masley C, Cao JQ, Jerzak KJ, Prakash I, Sehdev S, Simmons C, Bouganim N, et al. Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting. Current Oncology. 2024; 31(11):6536-6567. https://doi.org/10.3390/curroncol31110484

Manna, Mita, Karen A. Gelmon, Jean-François Boileau, Christine Brezden-Masley, Jeffrey Q. Cao, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, Christine Simmons, Nathaniel Bouganim, and et al. 2024. "Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting" Current Oncology 31, no. 11: 6536-6567. https://doi.org/10.3390/curroncol31110484

Manna, M., Gelmon, K. A., Boileau, J. -F., Brezden-Masley, C., Cao, J. Q., Jerzak, K. J., Prakash, I., Sehdev, S., Simmons, C., Bouganim, N., Brackstone, M., Cescon, D. W., Chia, S., Dayes, I. S., Edwards, S., Hilton, J., Joy, A. A., Laing, K., Webster, M., & Henning, J. -W. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting. Current Oncology, 31(11), 6536-6567. https://doi.org/10.3390/curroncol31110484